What is Barrington Research's Estimate for OPCH Q3 Earnings?

Key Points

• Analysts at Barrington Research have lowered their Q3 2025 earnings per share estimate for Option Care Health to $0.36, down from $0.37, while maintaining an "Outperform" rating with a price target of $38.00.
• JMP Securities and UBS Group have also raised their price targets for the stock to $38.00 and $40.00 respectively, with multiple analysts issuing buy ratings on Option Care Health.
• Despite a recent dip of 3.7%, Option Care Health reported quarterly earnings of $0.41 per share, surpassing the consensus estimate of $0.40 and achieving a year-over-year revenue increase of 15.4%.

Option Care Health, Inc. (NASDAQ:OPCH - Free Report) - Investment analysts at Barrington Research dropped their Q3 2025 EPS estimates for Option Care Health in a report released on Thursday, July 31st. Barrington Research analyst M. Petusky now expects that the company will earn $0.36 per share for the quarter, down from their prior estimate of $0.37. Barrington Research currently has a "Outperform" rating and a $38.00 price target on the stock. The consensus estimate for Option Care Health's current full-year earnings is $1.22 per share. Barrington Research also issued estimates for Option Care Health's Q4 2026 earnings at $0.47 EPS and FY2027 earnings at $1.92 EPS.

Several other analysts have also commented on OPCH. JMP Securities raised their price objective on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a report on Thursday, July 31st. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and increased their price target for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. Finally, Citigroup reissued an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $35.75.

Option Care Health Stock Performance

Shares of NASDAQ:OPCH traded down $0.23 during midday trading on Monday, reaching $27.68. The company's stock had a trading volume of 560,165 shares, compared to its average volume of 1,852,560. The firm has a market capitalization of $4.49 billion, a PE ratio of 22.14, a P/E/G ratio of 1.78 and a beta of 0.79. The stock has a fifty day moving average of $30.82 and a 200 day moving average of $31.94. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. Option Care Health has a twelve month low of $21.39 and a twelve month high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.40 by $0.01. The business had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The company's quarterly revenue was up 15.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.30 EPS.

Institutional Trading of Option Care Health

Several hedge funds have recently bought and sold shares of the stock. Public Employees Retirement System of Ohio boosted its position in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock worth $43,000 after acquiring an additional 332 shares in the last quarter. US Bancorp DE boosted its holdings in shares of Option Care Health by 5.0% in the 1st quarter. US Bancorp DE now owns 8,199 shares of the company's stock valued at $287,000 after purchasing an additional 393 shares in the last quarter. Assetmark Inc. raised its holdings in shares of Option Care Health by 1.6% during the 2nd quarter. Assetmark Inc. now owns 26,690 shares of the company's stock worth $867,000 after buying an additional 416 shares in the last quarter. Sheets Smith Wealth Management boosted its stake in Option Care Health by 1.9% in the second quarter. Sheets Smith Wealth Management now owns 24,938 shares of the company's stock valued at $810,000 after buying an additional 457 shares in the last quarter. Finally, State of Michigan Retirement System raised its stake in Option Care Health by 1.2% during the first quarter. State of Michigan Retirement System now owns 40,759 shares of the company's stock worth $1,425,000 after acquiring an additional 500 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.